Cite
Targeting NF-κB–dependent alkaliptosis for the treatment of venetoclax-resistant acute myeloid leukemia cells.
MLA
Zhu, Shan, et al. “Targeting NF-ΚB–dependent Alkaliptosis for the Treatment of Venetoclax-Resistant Acute Myeloid Leukemia Cells.” Biochemical & Biophysical Research Communications, vol. 562, July 2021, pp. 55–61. EBSCOhost, https://doi.org/10.1016/j.bbrc.2021.05.049.
APA
Zhu, S., Liu, J., Kang, R., Yang, M., & Tang, D. (2021). Targeting NF-κB–dependent alkaliptosis for the treatment of venetoclax-resistant acute myeloid leukemia cells. Biochemical & Biophysical Research Communications, 562, 55–61. https://doi.org/10.1016/j.bbrc.2021.05.049
Chicago
Zhu, Shan, Jiao Liu, Rui Kang, Minghua Yang, and Daolin Tang. 2021. “Targeting NF-ΚB–dependent Alkaliptosis for the Treatment of Venetoclax-Resistant Acute Myeloid Leukemia Cells.” Biochemical & Biophysical Research Communications 562 (July): 55–61. doi:10.1016/j.bbrc.2021.05.049.